Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic Arrhythmias

  title={Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic Arrhythmias},
  author={Michael Jelinek and Leif A. Lohrbauer and Bernard Lown},
Exercise stress testing and 24-hour ambulatory monitoring have been employed to evaluate antiarrhythmic drug efficacy in patients with sporadic ventricular ectopic arrhythmias (VEA). Twenty-three patients with often recurring VEA were exercised 123 times and subjected to 66 ambulatory monitoring sessions during control periods and while receiving either procaine amide or quinidine. Two dose schedules were employed; procaine amide, 3.0 and 6.0 g daily and quinidine, 1.2 and 1.8 g daily. Though… 

Tables from this paper

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
Encainide was a highly effective, well-tolerated antiarrhythmic agent and a single patient whose arrhythmia and electrocardiogram were unchanged during therapy eliminated the drug much more slowly than the others and was the only patient in whom no O-demethyl form could be detected in plasma, suggesting that this metabolite may be active.
Recurrent Sustained Ventricular Tachycardia 3. Role of the Electrophysiologic Study in Selection of Antiarrhythmic Regimens
This study suggests that serial EPS provides rapid identification of successful antiarrhythmic therapy and can predict in which patients conventional therapy would be ineffective, thereby identifying patients requiring more aggressive modes of therapy.
Ethmozin, A New Antiarrhythmic Drug for Suppressing Ventricular Premature Complexes
It is concluded that ethmozin appears to be a welltolerated, relatively effective agent for controlling VPCs.
Long-term antiarrhythmic therapy with acetylprocainamide.
Antiarrhythmic Drug Effect Mimicked by Spontaneous Variability of Ventricular Ectopy
Spontaneous variability in ventricular ectopic beats causes serious problems when using ECG monitoring to evaluate antiarrhythmic drug response in individual patients, so examining group response rather than individual patient response minimizes the effect of spontaneous variability.
The Effectiveness of Antiarrhythmic Agents on Early‐cycle Premature Ventricular Complexes
It is demonstrated that clinically important effects of procainamide and quinidine can occur in the absence of an overall reduction in the number of PVCs.
Aggravation and Provocation of Ventricular Arrhythmias by Antiarrhythmic Drugs
The data suggest that this potentially serious complication is not readily predictable and requires a systematic approach to antiarrhythmic drug testing before a patient is prescribed a long-range maintenance program.
A New Method for Evaluating Antiarrhythmic Drug Efficacy
Although standards for distinguishing antiarrhythmic drug effect from spontaneous variability of premature ventricular complexes were developed in patients with chronic ischemic heart disease, the model can be used to establish antiarrHythmmic drug efficacy in any patient group.


Long‐Term Use of Procaine Amide following Acute Myocardial Infarction
It is concluded that the high incidence of toxic reactions precludes widespread use of long-term prophylactic procaine amide therapy, and more precise identification of a sudden death-prone population might justify such therapy in such selected cases.
Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
Abstract The effectiveness of prophylactic therapy with procainamide in preventing active ventricular arrhythmias after acute myocardial infarction was determined in a double-blind study using
Occurrence of Ventricular Arrhythmias with Exercise as Compared to Monitoring
In addition to displaying an increased incidence of arrhythmia, exercise revealed more serious rhythm abnormalities which would not have been suspected on monitoring alone and was effective in patients with and without coronary heart disease.
Recorded Arrhythmias in an Acute Coronary Care Area
The use of Sodi-Pallares' polarizing solution appears to exert a definite anti-arrhythmic effect in preventing ventricular fibrillation, and studies should be undertaken to see if oral potassium associated with oral sodium diphenylmydantoin would have the same effect, and if intravenous glucose with insulin alone has a protective arrhythmmic action.
Sleep and Ventricular Premature Beats
It is concluded that treatment of sporadically occurring ventricular ectopic activity in some patients may require attention to the neurophysiologic trigger rather than the cardiac target.
Prognostic Significance of Ventricular Ectopic Beats with Respect to Sudden Death in the Late Postinfarction Period
It is suggested that the differential association with SCD between ventricular extrasystoles and parasystole in the late postinfarction period may have bearing on the mechanism of ventricular fibrillation and SCD.
Exercise stress testing for exposure of cardiac arrhythmia.
The Incidence of Arrhythmias in Acute Myocardial Infarction Studied with a Constant Monitoring System
Continuous cardiac monitoring has immediate practicality in the management of these patients, and might, if used as a guide to therapy, reduce the mortality from acute myocardial infarction.
Pathogenesis, Prevention, and Treatment of Arrhythmias in Myocardial Infarction
In a well-functioning CCU, death from electrical failure can now be nearly completely prevented and the focus of care is changed from resuscitation to that of abolishing minor arrhythmias.